SNTI Financial Statements

Balance sheet, income statement, cash flow, and dividends for Senti Biosciences Inc (SNTI).


$16.11M Market Cap.

As of 03/20/2025 5:00 PM ET (MRY) • Disclaimer

SNTI Market Cap. (MRY)


SNTI Shares Outstanding (MRY)


SNTI Assets (MRY)


Total Assets

$97.84M

Total Liabilities

$47.09M

Total Investments

$0

SNTI Income (MRY)


Revenue

$0

Net Income

-$52.79M

Operating Expense

$61.04M

SNTI Cash Flow (MRY)


CF Operations

-$41.40M

CF Investing

$34.00K

CF Financing

$53.73M

SNTI Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

SNTI Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$97,841,000 (-18.11%)

$119,484,000 (-33.91%)

$180,792,000 (86.96%)

$96,702,000 (100.02%)

Assets Current

$58,961,000 (-17.19%)

$71,200,000 (-30.59%)

$102,579,000 (70.42%)

$60,193,000 (89.83%)

Assets Non-Current

$38,880,000 (-19.48%)

$48,284,000 (-38.27%)

$78,213,000 (114.23%)

$36,509,000 (119.46%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$25,649,000 (-61.67%)

$66,913,000 (-47.42%)

$127,263,000 (214.18%)

-$111,457,000 (-89.83%)

Property Plant & Equipment Net

$35,237,000 (-15.32%)

$41,612,000 (-40.37%)

$69,779,000 (110.97%)

$33,076,000 (104.94%)

Cash & Equivalents

$51,815,000 (31.35%)

$39,448,000 (-35.32%)

$60,987,000 (2.86%)

$59,291,000 (91.05%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$1,000 (0%)

$0 (0%)

Deferred Revenue

$660,000 (-33.27%)

$989,000 (23.78%)

$799,000 (-56.39%)

$1,832,000 (0%)

Total Investments

$0 (0%)

$0 (0%)

$40,942,000 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$40,942,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$159,000 (41.96%)

$112,000 (-82.11%)

$626,000 (29.61%)

$483,000 (448.86%)

Trade & Non-Trade Payables

$1,454,000 (16.32%)

$1,250,000 (-8.76%)

$1,370,000 (-73.59%)

$5,187,000 (467.51%)

Accumulated Retained Earnings (Deficit)

-$297,134,000 (-21.60%)

-$244,344,000 (-41.01%)

-$173,286,000 (-50.58%)

-$115,076,000 (-92.57%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$33,641,000 (-10.69%)

$37,666,000 (1.55%)

$37,091,000 (63.17%)

$22,731,000 (61.80%)

Debt Current

$4,750,000 (15.07%)

$4,128,000 (107.65%)

$1,988,000 (14.06%)

$1,743,000 (14.75%)

Debt Non-Current

$28,891,000 (-13.86%)

$33,538,000 (-4.46%)

$35,103,000 (67.25%)

$20,988,000 (67.50%)

Total Liabilities

$47,086,000 (-10.43%)

$52,571,000 (-1.79%)

$53,529,000 (47.36%)

$36,326,000 (108.82%)

Liabilities Current

$13,146,000 (3.74%)

$12,672,000 (-29.81%)

$18,053,000 (24.14%)

$14,543,000 (198.87%)

Liabilities Non-Current

$33,940,000 (-14.94%)

$39,899,000 (12.47%)

$35,476,000 (62.86%)

$21,783,000 (73.85%)

SNTI Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$2,561,000 (-40.25%)

$4,286,000 (55.23%)

$2,761,000 (387.81%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$26,370,000 (-29.07%)

$37,176,000 (-8.99%)

$40,848,000 (92.23%)

$21,250,000 (128.40%)

Research & Development Expense

$34,356,000 (6.86%)

$32,150,000 (-5.63%)

$34,067,000 (55.15%)

$21,957,000 (37.61%)

Operating Expenses

$61,039,000 (-35.94%)

$95,288,000 (27.19%)

$74,915,000 (73.39%)

$43,207,000 (71.05%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

-$12,348,000 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$52,790,000 (25.71%)

-$71,058,000 (-22.07%)

-$58,210,000 (-5.23%)

-$55,319,000 (-178.52%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$52,790,000 (25.71%)

-$71,058,000 (-22.07%)

-$58,210,000 (-5.23%)

-$55,319,000 (-178.52%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$52,790,000 (25.71%)

-$71,058,000 (-22.07%)

-$58,210,000 (-5.23%)

-$55,319,000 (-178.52%)

Weighted Average Shares

$4,595,946 (-89.64%)

$44,372,223 (69.94%)

$26,110,785 (796.58%)

$2,912,275 (-78.99%)

Weighted Average Shares Diluted

$4,595,946 (-89.64%)

$44,372,223 (69.94%)

$26,110,785 (796.58%)

$2,912,275 (-78.99%)

Earning Before Interest & Taxes (EBIT)

-$52,790,000 (25.71%)

-$71,058,000 (-22.07%)

-$58,210,000 (-5.23%)

-$55,319,000 (-178.52%)

Gross Profit

$0 (0%)

$2,561,000 (-40.25%)

$4,286,000 (55.23%)

$2,761,000 (387.81%)

Operating Income

-$61,039,000 (34.17%)

-$92,727,000 (-31.29%)

-$70,629,000 (-74.63%)

-$40,446,000 (-63.79%)

SNTI Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$34,000 (-99.89%)

$30,077,000 (136.70%)

-$81,959,000 (-1378.60%)

-$5,543,000 (-148.80%)

Net Cash Flow from Financing

$53,730,000 (6797.30%)

$779,000 (-99.34%)

$118,551,000 (73.23%)

$68,435,000 (79.85%)

Net Cash Flow from Operations

-$41,397,000 (20.99%)

-$52,395,000 (-50.15%)

-$34,896,000 (-0.75%)

-$34,635,000 (-43.28%)

Net Cash Flow / Change in Cash & Cash Equivalents

$12,367,000 (157.42%)

-$21,539,000 (-1369.99%)

$1,696,000 (-94.00%)

$28,257,000 (11.97%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$42,010,000 (203.51%)

-$40,585,000 (0%)

$0 (0%)

Capital Expenditure

$34,000 (100.28%)

-$11,933,000 (71.16%)

-$41,374,000 (-646.42%)

-$5,543,000 (-377.43%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$108,000 (-102.09%)

$5,175,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$49,059,000 (5430.89%)

$887,000 (-99.22%)

$113,376,000 (7545.04%)

$1,483,000 (345.35%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,755,000 (-81.85%)

$9,670,000 (-41.01%)

$16,392,000 (614.25%)

$2,295,000 (743.75%)

Depreciation Amortization & Accretion

$5,851,000 (7.77%)

$5,429,000 (38.49%)

$3,920,000 (30.23%)

$3,010,000 (51.64%)

SNTI Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-

-2774.60% (-104.30%)

-1358.10% (32.22%)

-2003.60% (42.90%)

EBITDA Margin

-

-2562.60% (-102.31%)

-1266.70% (33.14%)

-1894.60% (40.02%)

Return on Average Equity (ROAE)

-148.80% (-88.35%)

-79.00% (89.28%)

-736.60% (-513.36%)

178.20%

Return on Average Assets (ROAA)

-61.30% (-19.96%)

-51.10% (-21.67%)

-42.00% (-6.33%)

-39.50%

Return on Sales (ROS)

-

-2774.60% (-104.30%)

-1358.10% (32.22%)

-2003.60% (42.90%)

Return on Invested Capital (ROIC)

-63.70% (-12.35%)

-56.70% (10.14%)

-63.10% (-44.39%)

-43.70%

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.29 (29.13%)

-0.41 (34.81%)

-0.63 (-21.77%)

-0.52

Price to Sales Ratio (P/S)

-

11.44 (33.12%)

8.59 (-17.40%)

10.4

Price to Book Ratio (P/B)

0.63 (43.05%)

0.44 (-9.67%)

0.49 (118.64%)

-2.61

Debt to Equity Ratio (D/E)

1.84 (133.59%)

0.79 (86.70%)

0.42 (229.14%)

-0.33 (-10.14%)

Earnings Per Share (EPS)

-12.03 (-651.88%)

-1.6 (28.25%)

-2.23 (88.26%)

-19 (-1228.67%)

Sales Per Share (SPS)

0 (0%)

0.06 (-64.63%)

0.16 (-82.70%)

0.95 (2212.20%)

Free Cash Flow Per Share (FCFPS)

-9 (-520.69%)

-1.45 (50.36%)

-2.92 (78.83%)

-13.8 (-654.70%)

Book Value Per Share (BVPS)

5.58 (270.09%)

1.51 (-69.06%)

4.87 (112.74%)

-38.27 (-803.68%)

Tangible Assets Book Value Per Share (TABVPS)

21.29 (690.53%)

2.69 (-61.11%)

6.92 (-79.15%)

33.2 (852.25%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0%)

0 (0%)

0 (0%)

-5

Enterprise Value Over EBITDA (EV/EBITDA)

-0.78 (-146.23%)

-0.32 (-177.37%)

0.41 (107.43%)

-5.54

Asset Turnover

0 (0%)

0.02 (-41.94%)

0.03 (55.00%)

0.02

Current Ratio

4.49 (-20.18%)

5.62 (-1.11%)

5.68 (37.28%)

4.14 (-36.48%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$41,363,000 (35.70%)

-$64,328,000 (15.66%)

-$76,270,000 (-89.83%)

-$40,178,000 (-58.59%)

Enterprise Value (EV)

$36,775,144 (76.09%)

$20,884,823 (193.65%)

-$22,301,521 (-107.70%)

$289,545,286

Earnings Before Tax (EBT)

-$52,790,000 (25.71%)

-$71,058,000 (-22.07%)

-$58,210,000 (-5.23%)

-$55,319,000 (-178.52%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$46,939,000 (28.48%)

-$65,629,000 (-20.89%)

-$54,290,000 (-3.79%)

-$52,309,000 (-192.61%)

Invested Capital

$66,521,000 (-36.66%)

$105,030,000 (-24.35%)

$138,843,000 (204.49%)

$45,599,000 (72.11%)

Working Capital

$45,815,000 (-21.72%)

$58,528,000 (-30.76%)

$84,526,000 (85.16%)

$45,650,000 (70.06%)

Tangible Asset Value

$97,841,000 (-18.11%)

$119,484,000 (-33.91%)

$180,792,000 (86.96%)

$96,702,000 (100.02%)

Market Capitalization

$16,106,144 (-45.22%)

$29,399,823 (-52.46%)

$61,838,479 (-78.72%)

$290,529,830

Average Equity

$35,471,250 (-60.54%)

$89,901,250 (1037.56%)

$7,903,000 (125.46%)

-$31,044,052

Average Assets

$86,165,000 (-38.04%)

$139,076,250 (0.24%)

$138,747,000 (-1.01%)

$140,155,625

Invested Capital Average

$82,893,750 (-33.82%)

$125,255,250 (35.82%)

$92,221,000 (-27.23%)

$126,724,589

Shares

4,588,645 (-89.70%)

44,545,186 (1.57%)

43,857,077 (48.84%)

29,465,500